期刊文献+

重症患者连续性肾脏替代治疗中管路寿命影响因素的研究 被引量:2

Influencing factor on circuit life span in critically ill patients with continuous renal replacement therapy
原文传递
导出
摘要 目的探讨影响重症病患者连续性肾脏替代治疗(CRRT)中管路寿命的因素。方法将131个因为管路凝结而更换配套的滤器分成两组,寿命<48h的为A组(106个),≥48h的为B组(25个)。比较两组管路滤器应用时患者的血清白蛋白、红细胞压积、血小板计数、离子钙浓度、pH值、活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、肝素剂量及体温的变化,并采用多因素线性回归对上述指标进行分析。结果 B组患者血清离子钙浓度、pH值及体温明显低于A组患者(P均<0.05)。血PH值及离子钙浓度是影响管路滤器寿命≥48h的相关因素。结论影响CRRT管路寿命≥48h的相关因素是血pH值和离子钙浓度。 Objective To explore the influencing factor of circuit life span in critically ill patients with continuous renal replacement therapy (CRRT). Methods A total of 131 filters in 32 patients with CRRT were divided into group A (circuit life 〈 48 h, 106 filters) and group B (circuit life ≥48 h, 25 filters). The levels of serum albumin, hematocrit, platelet, plasma ionized calcium, pH value, activated partial thromboplastin time (APTT), prothrombin time (PT), dose of heparin and temperature were recorded and compared. The muhivariate liner regress was used to analyze the correlation factor of circuit life ≥ 48 h. Results The levels of plasma ionized calcium, pH value and temperature in group B were much lower than those in group A (all P 〈 0.05). The multivariate liner regress analysis showed an association between the circuit life ≥ 48 h and plasma ionized calcium and pH value. Conclusion The plasma ionized calcium and pH value can effect circuit life ≥ 48 h in patients with CRRT.
出处 《中华危重症医学杂志(电子版)》 CAS 2012年第5期11-14,共4页 Chinese Journal of Critical Care Medicine:Electronic Edition
基金 浙江省金华市科学技术局资助项目(2007-3-039)
关键词 肾替代疗法 管路寿命 危重病 Renal replacement therapy Circuit life span Critical illness
  • 相关文献

参考文献20

  • 1Monti G,Herrera M,Kindgen-Milles D. The dose response multicentre International collaborative initiative (DO-RE-MI)[J].Contributions to Nephrology,2007.434-443.
  • 2Holt AW,Bierer P,Bersten AD. Continuous renal replacement therapy in critically ill patients:monitoring circuit function[J].Anaesthesia and Intensive Care,1996,(04):423-429.
  • 3Uchino S,Fealy N,Baldwin I. Pre-dilution vs.post-dilution during continuous veno-venous hemofiltration:impact on filter life and azotemic control[J].NEPHRON CLINICAL PRACTICE,2003,(04):e94-e98.
  • 4del Castillo J,López-Herce J,Cidoncha E. Circuit life span in critically ill children on continuous renal replacement treatment:a prospective observational evaluation study[J].Critical Care,2008,(04):R93.
  • 5谭惠珍(综述),陈江华(审校).连续性肾脏替代治疗中抗凝技术的研究进展[J].国际移植与血液净化杂志,2007,5(3):1-4. 被引量:7
  • 6Jander A,Tkaczyk M,Pagowska-Klimek 1. Continuous veno-venous hemodiafiltration in children after cardiac surgery[J].European Journal of Cardio-Thoracic Surgery,2007,(06):1022-1028.doi:10.1016/j.ejcts.2007.03.001.
  • 7Kim IB,Fealy N,Ballwin I. Insertion side,body position and circuit life during continuous renal replacement therapy with femoral vein access[J].Blood Purification,2011,(1-3):42-46.
  • 8Meng ZH,Wolberg AS,Monroe DM 3rd. The effect of temperature and pH on the activity of factor VIIa:implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients[J].Journal of Trauma-Injury Infection and Critical Care,2003,(05):886-891.
  • 9Darlington DN,Kheirabadi BS,Delgado AV. Coagulation changes to systemic acidosis and bicarbonate correction in swine[J].Journal of Trauma-Injury Infection and Critical Care,2011,(05):1271-1277.
  • 10Mann KG,Brummel K,Butenas S. What is all that thrombin for[J].Journal of Thrombosis and Haemostasis,2003,(07):1504-1514.

二级参考文献38

  • 1王海涛,毛永辉,李胜利,吴华.枸橼酸-葡萄糖抗凝溶液在高危出血患者连续性血液净化中的应用[J].中华肾脏病杂志,2006,22(3):166-169. 被引量:11
  • 2Van Bommel EFH;Ponssen HH.查看详情,1997(zk).
  • 3Kim S S;Lee H;Na B K;Song H K.查看详情,2003(05).
  • 4Dhondt A;Vanholder R;Tielemans C.查看详情,2000(04).
  • 5Hampers CL;Blaufox MD;Merrill JP.查看详情[J],1966.
  • 6Frank RD;Muller U;Lanzmich R.Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.[J],2006(04).
  • 7Lee KB;Kim B;Lee YH.The Use of Nanoarrays for Highly Sensitive and Selective Detection of Human Immunodeficiency Virus Type 1 in Plasma[J],2004(01).
  • 8王淑芬;李冀军;杜娟.查看详情,1995(05).
  • 9Inagaki O;Nishian Y;Iwaki R.查看详情[J],1992.
  • 10Miyata M;Shirakawa T;Acharya B.Effects of nafamostat mesilate on ADP-induced platelet aggregation and disaggregation in hemodialysis patients.[J],2006(03).

共引文献6

同被引文献16

  • 1Zhang Z,Ni H,Lu B.Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy:a prospective observational study.ASAIO J.2012 Jan-Feb;58(1):46-50.
  • 2Baldwin I,Bellomo R,Koch B:Blood flow reductions during continuous renal replacement therapy and circuit life.Intensive Care Med,2004;30(11):2074-2079.
  • 3Sponholz C,Bayer O,Kabisch B,et al.Anticoagulation strategies in venovenous hemodialysis in critically ill pa- tients:a five 一 year evaluation in a surgical intensive care unit.ScientificWorldJoumal.2014;2014:808320.
  • 4Beitland SI,Sunde K,Moen H,et al.Variability in Uremic Control during Continuous Venovenous Hemodi- afiltration in Trauma Patients.Crit Care Res Pract.2012;2012:869237.
  • 5Urbani A,Sirolli V,Lupisella S,et al.Proteomic investi- gations on the effect of different membrane materials on blood protein adsorption during haemodialysis.Blood Transfus.2012;10 Suppl 2:sl01-12.
  • 6Baldwin I,Fealy N,Carty P,et al.Bubble Chamber Clotting during Continuous Renal Replacement Thera- py; Vertical versus Horizontal Blood Flow Entry[J].Blood Purif,2012,34(3-4):213-218.
  • 7Shimaoka M,Park EJ.Advances in understanding sepsis[J].Eur J Anaesthesiol,2008,25(42):146-153.
  • 8Levi M,Schultz M.The inflammation-coagulation axis as an important intermediate pathway in acute lung inju- ry[J].Crit Care,2008,12(2):144-147.
  • 9Lissalde-Lavigne G,Combescure C,Muller L,et al.Simple coagulation tests improve survival predic- tion in patients with septic shock[J].J Thrombo Haemost,2008,6(4):645-653.
  • 10沈云峰,胡远贵,田强,张洪波.心血管疾病同型半胱氨酸水平与血液流变学指标的相关性[J].检验医学与临床,2009,6(4):241-242. 被引量:13

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部